{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:22:24Z","timestamp":1791559344294,"version":"4.3.4"},"reference-count":39,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1507\/endocrj.ej21-0447","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T22:08:30Z","timestamp":1640124510000},"page":"577-583","source":"Crossref","is-referenced-by-count":10,"title":["Impact of salt intake on urinary albumin excretion in patients with type 2 diabetic nephropathy: a retrospective cohort study based on a generalized additive model"],"prefix":"10.1507","volume":"69","author":[{"given":"Yuka","family":"Kotake","sequence":"first","affiliation":[{"name":"Division of Economics, Graduate School of Human and Socio-Environmental Studies, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehiro","family":"Karashima","sequence":"additional","affiliation":[{"name":"Institute of Liberal Arts and Science, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kawakami","sequence":"additional","affiliation":[{"name":"School of Electrical, Information, and Communication Engineering, College of Science and Engineering, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hara","sequence":"additional","affiliation":[{"name":"Medical Education Research Center, Kanazawa University, Medical Education Research Center, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Aono","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Hospital, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Hospital, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Kometani","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Hospital, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Mori","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School, Department of Molecular & Integrative Physiology, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyu","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Asanogawa General Hospital, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kanazawa University Hospital, Kanazawa, Japan"},{"name":"Institute of Transdisciplinary Sciences, Kanazawa University, Kanazawa, Japan"},{"name":"Department of Health Promotion and Medicine of the Future, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Nambo","sequence":"additional","affiliation":[{"name":"School of Electrical, Information, and Communication Engineering, College of Science and Engineering, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Center of Diabetes and Metabolism, Japan Community Healthcare Organization Kanazawa Hospital, Kanazawa, Japan"},{"name":"Health Care Center, Japan Advanced Institute of Science and Technology, Nomi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Rotz E, Rychlik I, Locatelli F, Halimi S (1999) End stage renal failure in type 2 diabetes: a medical catastrophe of world wide dimensions. Am J Kidney Dis 34: 795\u2013808.","DOI":"10.1016\/S0272-6386(99)70035-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Byme C, Steenkamp R, Castledine C, Ansell D, Feehally J (2010) UK renal registry 12th annual report: chapter 4: UK ESRD prevalent rates in 2008: national and centre-specific analysis. Nephron Clin Pract 115: c41\u2013c67.","DOI":"10.1159\/000301159"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Masakane I, Nakai S, Ogata S, Kimata N, Hanafusa N, et al. (2015) An overview of regular dialysis treatment in Japan (as of 31 December 2013). Ther Apher Dial 19: 540\u2013574.","DOI":"10.1111\/1744-9987.12378"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4 Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, et al. (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28: 164\u2013176.","DOI":"10.2337\/diacare.28.1.164"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Navaneethan SD, Zoungas S, Caramori ML, Chan JCN, Heerspink HJL, et al. (2021) Diabetes management in chronic kidney disease: synopsis of the 2020 KDIGO clinical practice guideline. Ann Intern Med 174: 385\u2013394.","DOI":"10.7326\/M20-5938"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Foley RN, Collins AJ (2009) The growing economic burden of diabetic kidney disease. Curr Diab Rep 9: 460\u2013465.","DOI":"10.1007\/s11892-009-0075-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Mogensen CE (1987) Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31: 673\u2013689.","DOI":"10.1038\/ki.1987.50"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Haneda M, Noda M, Origasa H, Noto H, Yabe D, et al. (2018) Japanese clinical practice guideline for diabetes 2016. Diabetol Int 9: 1\u201345.","DOI":"10.1007\/s13340-018-0345-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 American Diabetes Association (2019) 5. Lifestyle management: standards of medical care in diabetes-2019. Diabetes Care 42: S46\u2013S60.","DOI":"10.2337\/dc19-S005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Hwang TJ, Kesselheim AS, Vokinger KN (2019) Lifecycle regulation of artificial intelligence- and machine learning-based software devices in medicine. JAMA 322: 2285\u20132286.","DOI":"10.1001\/jama.2019.16842"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Shortliffe EH, Sep\u00falveda MJ (2018) Clinical decision support in the era of artificial intelligence. JAMA 320: 2199\u20132200.","DOI":"10.1001\/jama.2018.17163"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Tjoa E, Guan C (2021) A survey on explainable artificial intelligence (XAI): toward medical XAI. IEEE Trans Neural Netw Learn Syst 32: 4793\u20134813.","DOI":"10.1109\/TNNLS.2020.3027314"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Ribeiro MT, Singh S, Guestrin C (2016) \u201cWhy should I trust you?\u201d Explaining the predictions of any classifier. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. Association for Computing Machinery, New York, USA; 1135\u20131144.","DOI":"10.1145\/2939672.2939778"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Hastie T, Tibshirani R (1995) Generalized additive models for medical research. Stat Methods Med Res 4: 187\u2013196.","DOI":"10.1177\/096228029500400302"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Haneda M, Utsunomiya K, Koya D, Babazono T, Moriya T, et al. (2015) A new classification of diabetic nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy. Clin Exp Nephrol 19: 1\u20135.","DOI":"10.1007\/s10157-014-1057-z"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Umemura S, Arima H, Arima S, Asayama K, Dohi Y, et al. (2019) The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res 42: 1235\u20131481.","DOI":"10.1038\/s41440-019-0284-9"},{"key":"17","unstructured":"17 Fisher A, Rudin C, Dominici F (2019) All models are wrong, but many are useful: learning a variable\u2019s importance by studying an entire class of prediction models simultaneously. J Mach Learn Res 20: 177."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Tuck M, Corry D, Trujillo A (1990) Salt-sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus. Am J Med 88: 210\u2013216.","DOI":"10.1016\/0002-9343(90)90144-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Underwood PC, Chamarthi B, Williams JS, Vaidya A, Garg R, et al. (2012) Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus. J Clin Endocrinol Metab 97: 3775\u20133782.","DOI":"10.1210\/jc.2012-2127"},{"key":"20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","volume":"393","year":"2019","unstructured":"20 Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, et al. (2019) SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet 393: 31\u201339.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Reisin E, Messerli FH (1995) Obesity-related hypertension: mechanisms, cardiovascular risks and heredity. Curr Opin Nephrol Hypertens 4: 67\u201371.","DOI":"10.1097\/00041552-199501000-00010"},{"key":"22","unstructured":"22 Strippoli GF, Di Paolo S, Cincione R, Di Palma AM, Teutonico A, et al. (2003) Clinical and therapeutic aspects of diabetic nephropathy. J Nephrol 16: 487\u2013499."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, et al. (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63: 225\u2013232.","DOI":"10.1046\/j.1523-1755.2003.00712.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Kitada M, Kanasaki K, Koya D (2014) Clinical therapeutic strategies for early stage of diabetic kidney disease. World J Diabetes 5: 342\u2013356.","DOI":"10.4239\/wjd.v5.i3.342"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25 Suckling RJ, He FJ, Markandu ND, MacGregor GA (2016) Modest salt reduction lowers blood pressure and albumin excretion in impaired glucose tolerance and type 2 diabetes mellitus: a randomized double-blind trial. Hypertension 67: 1189\u20131195.","DOI":"10.1161\/HYPERTENSIONAHA.115.06637"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Suckling RJ, He FJ, Macgregor GA (2010) Altered dietary salt intake for preventing and treating diabetic kidney disease. Cochrane Database Syst Rev 8: CD006763.","DOI":"10.1002\/14651858.CD006763.pub2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, et al. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383\u2013393.","DOI":"10.1056\/NEJMoa021778"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358: 580\u2013591.","DOI":"10.1056\/NEJMoa0706245"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, et al. (2017) Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet Diabetes Endocrinol 5: 951\u2013964.","DOI":"10.1016\/S2213-8587(17)30327-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Shikata K, Haneda M, Ninomiya T, Koya D, Suzuki Y, et al. (2021) Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan). J Diabetes Investig 12: 207\u2013216.","DOI":"10.1111\/jdi.13339"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Kuzhively J, Tahsin B, Hart P, Fogelfeld L (2018) Legacy effect in combined diabetic-renal multifactorial intervention in patients with advanced diabetic nephropathy. J Diabetes Complications 32: 474\u2013479.","DOI":"10.1016\/j.jdiacomp.2018.02.001"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Yokoyama H, Oishi M, Takamura H, Yamasaki K, Shirabe SI, et al. (2016) Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40). BMJ Open Diabetes Res Care 4: e000294.","DOI":"10.1136\/bmjdrc-2016-000294"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33 Kahn R, Davidson MB (2014) The reality of type 2 diabetes prevention. Diabetes Care 37: 943\u2013949.","DOI":"10.2337\/dc13-1954"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Maillot M, Drewnowski A (2012) A conflict between nutritionally adequate diets and meeting the 2010 dietary guidelines for sodium. Am J Prev Med 42: 174\u2013179.","DOI":"10.1016\/j.amepre.2011.10.009"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35 Tate DF, Jackvony EH, Wing RR (2003) Effects of internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial. JAMA 289: 1833\u20131836.","DOI":"10.1001\/jama.289.14.1833"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Wadden TA, Volger S, Sarwer DB, Vetter ML, Tsai AG, et al. (2011) A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med 365: 1969\u20131979.","DOI":"10.1056\/NEJMoa1109220"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Appel LJ, Clark JM, Yeh HC, Wang NY, Coughlin JW, et al. (2011) Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med 365: 1959\u20131968.","DOI":"10.1056\/NEJMoa1108660"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Heshka S, Anderson JW, Atkinson RL, Greenway FL, Hill JO, et al. (2003) Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA 289: 1792\u20131798.","DOI":"10.1001\/jama.289.14.1792"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Ma J, Yank V, Xiao L, Lavori PW, Wilson SR, et al. (2013) Translating the diabetes prevention program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern Med 173: 113\u2013121.","DOI":"10.1001\/2013.jamainternmed.987"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/5\/69_EJ21-0447\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:22:28Z","timestamp":1715232148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/5\/69_EJ21-0447\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej21-0447","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"EJ21-0447"}}